Procurement Summary
Country: USA
Summary: Marburg virus (MARV) and Sudan virus (SUDV) Vaccines
Deadline: 27 Aug 2025
Other Information
Notice Type: Tender
TOT Ref.No.: 123724163
Document Ref. No.: 75A50125R00006
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Description
The 2014 Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) Strategy and Implementation Plan identifies Ebola virus and Marburg virus as high-priority threats as determined by the Department of Homeland Security to present a material threat to national security. Strategies to mitigate the threat of Ebola virus and Marburg virus include the development of vaccines suitable for protection against Ebola and Marburg virus disease respectively. BARDA is seeking vaccines that can be safely and effectively used for the U.S. civilian population in individuals with an elevated risk of exposure to Sudan virus (SUDV) and Marburg virus (MARV).
This acquisition will allow BARDA to invest Project BioShield funds for the advanced development, US Food and Drug Administration (FDA) licensure, procurement, shipping, and vendor managed inventory (VMI) storage of MARV and SUDV monovalent vaccines.
Active Contract Opportunity
Notice ID : 75A50125R00006
Related Notice : 75A50125R00006
Department/Ind. Agency : HEALTH AND HUMAN SERVICES, DEPARTMENT OF
Sub-tier : OFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSE
Office: BARDA - ASPR / DAAPPO / BARDA DCMA
General Information
Contract Opportunity Type: Solicitation (Updated)
Updated Published Date: Jul 31, 2025 03:35 pm EDT
Original Published Date: Jul 13, 2025 10:24 pm EDT
Updated Date Offers Due: Aug 27, 2025 02:00 pm EDT
Original Date Offers Due: Aug 26, 2025 02:00 pm EDT
Inactive Policy: 15 days after date offers due
Updated Inactive Date: Sep 11, 2025
Original Inactive Date: Sep 10, 2025
Initiative: None
Classification
Original Set Aside: No Set aside used
Product Service Code: 6505 - DRUGS AND BIOLOGICALS
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Place of Performance: Washington, DC USA
Documents
Tender Notice
75A50125R00006-Amendment-2.pdf
75A50125R00006-QA.pdf